Dave Andrews, Meridian HealthComms; Guy Yeoman, Mallinckrodt Pharmaceuticals; Tom Grant, UCB; Catherine Skobe, Pfizer This article is derived from a plenary session delivered at the 17th Annual Meeting of ISMPP, April 12-14, 2021. In any relationship, whether business...
Richa Chhabra, MS (Pharm), ISMPP CMPP™, Adelphi Communications Limited, UK; Sally Hassan, PhD, ISMPP CMPP™, UK; Lana Vegman, PharmD, ISMPP CMPP™, Novartis Pharmaceuticals, US What does a Medical Affairs team look like at a pharmaceutical/biotechnology company? Is it...
Angela Sykes, MA, MPhil, Pfizer Inc., New York, NY; Beth Whann, BA, ISMPP CMPPTM, Pfizer Inc., Collegeville, PA; Stephanie Dooley, PharmD, Pfizer Inc., Collegeville, PA Scientific publications tend to be written with a specialized audience in...
Dawn Lobban, PhD, Envision Pharma Group, Wilmslow, UK; Jacqui Oliver, PhD, Envision Pharma Group, Wilmslow, UK; Alexandra Freeman, DPhil, University of Cambridge, UK; Simon Stones, BSc (Hons), Envision Pharma Group, Wilmslow, UK; Abbie Pound, BSc/BA, Ipsen, Slough, UK...
Michelle Kissner, PharmD, Pfizer Inc, New York, NY; Devy Lee, BSc (Pharm), ISMPP CMPP™, Pfizer Inc, Lake Forest, IL This article shares information about Pfizer’s experience with the need to develop guidelines and adjust processes, given the impact of the COVID-19...
Todd Parker, PhD, ISMPP CMPP™, MedThink SciCom; Robert J. Matheis, PhD, MA, ISMPP CMPP™, International Society for Medical Publication Professionals (ISMPP) As the medical communications field rapidly evolves, the scale and scope of our profession are expanding....
